Enabling affordable access to CAR-T cell and other cellular gene therapy products
Cell & Gene Therapy Insights 2024; 10(4), 425–430
DOI: 10.18609/cgti.2024.056
Published: 13 May
Viewpoint
“...global access to CGT like CAR-T cell and stem cell-based gene therapies is a growing problem...”